Peptic ulcer disease (PUD) remains a prevalent condition worldwide, necessitating an updated understanding of its pathophysiology, diagnosis, and treatment. This article presents a comprehensive approach to PUD, highlighting recent advancements in management and treatment strategies.
While Helicobacter pylori and nonsteroidal anti-inflammatory drugs (NSAIDs) remain the primary etiological agents, recent studies underscore the role of genetic predisposition, stress, and other lifestyle factors. An individualized approach to PUD, considering these multifactorial causes, optimizes patient outcomes.
Endoscopy continues to be the gold standard for PUD diagnosis. However, non-invasive tests like urea breath tests, stool antigen tests, and serologic tests for H. pylori have gained prominence due to their convenience and accuracy.
First-line treatment for PUD involves eradicating H. pylori with triple or quadruple therapy, alongside proton pump inhibitors (PPIs). For NSAID-induced ulcers, discontinuation of NSAIDs and PPI therapy are recommended. Recent advancements include the use of vonoprazan, a potassium-competitive acid blocker, showing superior efficacy to PPIs in certain populations. Moreover, the role of probiotics in enhancing H. pylori eradication and reducing side effects of antibiotics is gaining recognition.
Healthcare professionals must educate patients about lifestyle modifications, such as avoiding NSAIDs, limiting alcohol, and cessation of smoking. Emphasizing the importance of adherence to medication regimens is crucial to prevent recurrence.
Managing PUD effectively requires an updated, comprehensive approach considering the latest advancements in pathophysiology, diagnosis, and treatment. An individualized treatment plan, coupled with patient education, can significantly improve patient outcomes and prevent recurrence. As healthcare professionals, our role in staying abreast with these updates and implementing them in practice is vital.
1.
When does a melanoma metastasize? Implications for management
2.
Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets
3.
Mammography with AI support is a secure method for detecting breast cancer.
4.
Compared to previous estimates, a greater number of patients participate in cancer treatment trials.
5.
The biology of cancer as well as potential treatment options are examined by experts.
1.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
2.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
3.
Tumor-Associated Stroma Regeneration Models
4.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
5.
Immunotherapy Tolerance in Older Adults With Cancer
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation